Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
6.90
+0.67 (10.75%)
At close: Mar 12, 2026, 4:00 PM EDT
6.78
-0.12 (-1.74%)
After-hours: Mar 12, 2026, 4:19 PM EDT

Atara Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
23.4-85.4-276.13-228.3-340.14-306.62
Depreciation & Amortization
3.175.054.835.659.358.33
Stock-Based Compensation
14.082745.3953.8453.8751.35
Other Adjustments
17.4515.5917.59-40.153.832.49
Change in Receivables
-0.5832.636.11-39.240.26-1.25
Changes in Inventories
10.5-4.43-8.12-1.59--
Changes in Accounts Payable
-1.830.69-3.13-9.219.07-0.82
Changes in Accrued Expenses
-17.17-26.811.266.123.9513.04
Changes in Unearned Revenue
-115.8-20.330.4-11.4735.2261.25
Changes in Other Operating Activities
-0.28-12.72-11.18-6.094.09-8.54
Operating Cash Flow
-69.71-68.72-192.98-270.43-220.52-180.76
Capital Expenditures
-0.09-0.25-1.22-4.19-10.58-4.51
Sale of Property, Plant & Equipment
0.22-0.0394.77--
Purchases of Investments
-17.72-19.67-83.65-180.59-301.13-425.87
Proceeds from Sale of Investments
29.2728.54208.71292.97333.97309.65
Investing Cash Flow
13.088.62123.87202.9622.26-120.73
Issuance of Common Stock
16.2660.183.0623.81105.46429.65
Repurchase of Common Stock
0.23--0.09-0.62-1.24-1.52
Net Common Stock Issued (Repurchased)
16.4960.182.9723.19104.22428.13
Other Financing Activities
-0.49-0.9-0.9629.9-0.27-0.55
Financing Cash Flow
15.7759.282.0153.08103.94427.57
Net Cash Flow
-40.86-0.81-67.1-14.39-94.32126.09
Free Cash Flow
-69.8-68.96-194.2-274.62-231.1-185.27
FCF Margin
-213.12%-53.48%-2265.25%-431.98%-1136.19%-
Free Cash Flow Per Share
-5.89-9.21-45.85-67.32-61.68-62.61
Levered Free Cash Flow
-98.11-144.18-263.29-249.08-289.06-237.87
Unlevered Free Cash Flow
-95.3-142.21-263.19-301.3-289.42-240.31
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q